Mali Country Commercial Guide
Learn about the market conditions, opportunities, regulations, and business conditions in mali, prepared by at U.S. Embassies worldwide by Commerce Department, State Department and other U.S. agencies’ professionals
Select Country Guide
Pharmaceuticals
Last published date:

Overview

U.S. companies enjoy a competitive advantage in the pharmaceuticals sector.  However, illegal imports and the import of counterfeit pharmaceutical products pose significant problems.  In addition to traditional wholesalers and retailers, Mali’s large informal sector imports and sells pharmaceuticals without authorization.  Mali’s first pharmaceutical factory has had financial difficulties and has produced only limited products for domestic consumption.  A second pharmaceutical factory opened in 2018.

Leading Sub-Sectors

Mali imports numerous pharmaceutical products and the sector is dynamic.  Due to lack of factories, expertise, and infrastructure, Mali will continue to import large quantities of all kinds of pharmaceuticals in the next several years.  However, illegal imports will likely continue to be a problem.

Opportunities

The likelihood of successful pharmaceutical sales will be greatly increased by using a local representative with an existing distribution network of small and large pharmacies.  Having local partners that are also registered with Mali’s pharmaceutical guild and the Ministry of Health will also ensure Malian authorities can provide support in cases of counterfeit medicines and illegal importation.

Resources

  • Order of Pharmacists’ website: https://ordrepharmacien.ml/  
  • Embassy Bamako’s Commercial Section: BamakoEcon@state.gov

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility